CRYOSTAT-2 @ St Emlyns
Big news for the UK this week, with the release of 2 publications in JAMA reflecting novel approaches to the management of the major trauma patient with active haemorrhage. (1,2) …
Coagulopathy
JC: The PATCH trial. TXA in major trauma. St Emlyn’s
Critical Appraisal of the The PATCH trial of TXA Tranexamic Acid in major trauma patients. TXA saves lives, but functional outcomes vary. #FOAMed @stemlyns
JC: Early plasma use in traumatic brain injury. St Emlyn’s
There seems to be a lot of really interesting papers on Traumatic Brain Injury (TBI) this year. A welcome relief from COVID 19 perhaps but also a reminder that other …
JC: Early plasma use in traumatic brain injury. St Emlyn’s Read More »
JC: Blood Products in Trauma – What’s the Best (I)TACTIC?
Bleeding trauma patients present a couple of challenges to us in the Emergency Department. Increasingly, our aging population continues to engage in energetic daily pursuits while increasing numbers are prescribed …
JC: Blood Products in Trauma – What’s the Best (I)TACTIC? Read More »
New NICE Guidelines on diagnosis and management of venous thromboembolism
In the midst of everything that is going on with COVID-19 it is easy to see how important non coronavirus stuff can get overlooked. But we still need to keep …
New NICE Guidelines on diagnosis and management of venous thromboembolism Read More »
JC: AVP in Haemorrhagic Shock. St Emlyn’s
Blood product transfusion can be lifesaving for patients who have suffered major trauma, but the associated side-effects and risks, mean that most people would agree that less is more. This …
St Emlyn’s April 2018 blog and podcast round up.
Simon and Iain talk through what the team has been up to in April. All the blogs should be on the website and of course you can subscribe to the …
St Emlyn’s April 2018 blog and podcast round up. Read More »
CRYOSTAT-2 with Ross Davenport
You might be aware that an exciting new trial has started called Cryostat-2. Â This is exciting as it has the potential to improve patient outcomes, but also because it will …